Andexanet Alfa-Induced Heparin Resistance: When Anticoagulation Really Remains Reversed
J Cardiothorac Vasc Anesth
.
2021 Mar;35(3):908-909.
doi: 10.1053/j.jvca.2020.11.052.
Epub 2020 Nov 28.
Authors
Gabor Erdoes
1
,
Ingvild Birschmann
2
,
Michael Nagler
3
,
Andreas Koster
4
Affiliations
1
Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
2
Institute of Laboratory and Transfusion Medicine, Heart, and Diabetes Center NRW, Ruhr University Bochum, Bad Oeynhausen, Germany.
3
University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
4
Institute of Anesthesiology and Pain Therapy, Heart, and Diabetes Center NRW, Ruhr University Bochum, Bad Oeynhausen, Germany.
PMID:
33339660
DOI:
10.1053/j.jvca.2020.11.052
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anticoagulants / adverse effects
Antithrombins*
Factor Xa
Heparin* / adverse effects
Humans
Recombinant Proteins
Substances
Anticoagulants
Antithrombins
PRT064445
Recombinant Proteins
Heparin
Factor Xa